Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...

Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that five abstracts, including one late-breaker, ...

Non-retail Specialty Drugs Market forecast to 2035 highlights market size and key therapeutic trends. It focuses on growing demand for complex therapies through specialized healthcare channels.

For weeks, no one could tell Dr. Charles DeCarli whether the $53 million grant powering his lab’s ambitious dementia research ...

Autoimmune diseases are known for being critical to handle and treat, but today, with the advancements in modern medicines ...

Billion CAGR (2024-2030): 3.65% Market Segmentation: Reagent Type, Technology, Application, End-users, and Geography ...